RIGImmune
Pre-clinicalRIGImmune is a biopharmaceutical company developing a new class of immune-modulating therapies.
Founded
2017
Focus
Drug DeliveryRNA & Gene TherapySmall Molecules
About
RIGImmune is a biopharmaceutical company developing a new class of immune-modulating therapies.
Funding History
2Total raised: $16.5M
Series A$12MNorthpond VenturesJun 15, 2022
Seed$4.5MYale UniversityJun 15, 2020
Company Info
TypePrivate
Founded2017
LocationNew Haven, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile